• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对患有皮肤慢性移植物抗宿主病患者具有重要意义的结局。

Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease.

作者信息

Baumrin Emily, Cronholm Peter F, Kearney Matthew D, Mengesha Mlka, Cesar Laura G, Keddem Shimrit, Schapira Marilyn M, Lee Stephanie J, Loren Alison W, Gelfand Joel M

机构信息

Department of Dermatology, University of Pennsylvania, Philadelphia.

Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia.

出版信息

JAMA Dermatol. 2025 Mar 1;161(3):281-290. doi: 10.1001/jamadermatol.2024.5380.

DOI:10.1001/jamadermatol.2024.5380
PMID:39745736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11923722/
Abstract

IMPORTANCE

Cutaneous chronic graft-vs-host disease (GVHD) is independently associated with morbidity and mortality after allogeneic hematopoietic cell transplant. However, the health-related quality-of-life (HRQOL) domains that are most important to patients are poorly understood.

OBJECTIVE

To perform a concept elicitation study to define HRQOL in cutaneous chronic GVHD from the patient perspective and to compare experiences of patients with epidermal vs sclerotic disease.

DESIGN, SETTING, AND PARTICIPANTS: A single-center qualitative analysis from open-ended, semistructured interviews and free-listing terms conducted between April and September 2023. Participants were 18 years or older with a diagnosis of active cutaneous chronic GVHD, purposefully sampled for epidermal and sclerotic disease features, with ongoing sampling until thematic saturation.

MAIN OUTCOMES

HRQOL domains and codes from patient perspectives of living with cutaneous chronic GVHD were identified by inductive analysis of semistructured interviews. Smith salience index (Smith S) score, a measure of saliency for each list term, was calculated from free-listing terms from deidentified patient interviews.

RESULTS

A total of 31 adults with cutaneous chronic GVHD (median [IQR] age, 61.1 [52.9-68.7] years) participated in interviews; 17 participants (54.8%) were male and 14 (45.2%) were female. Nine participants (29.0%) had epidermal, 13 (41.9%) sclerotic, and 9 (29.0%) a combination of disease types. The study identified 40 codes of importance grouped within 5 HRQOL domains: skin changes and symptoms, social functioning, psychological and emotional functioning, physical functioning, and general health perceptions. The most frequent symptoms were dry skin (n = 20 [65%]), tight skin (n = 19 [61%]), itch (n = 15 [48%]), and discoloration (n = 14 [45%]), which were seen in all disease subtypes. Impairment in social functioning was noted by all participants. Psychological and emotional functioning, including frustration (Smith S score, 0.32) and worry or concern (Smith S score, 0.12), and symptoms including discomfort (Smith S score, 0.20) were the most salient to patients. Individual and environmental factors, such as social comparison, illness comparison with cancer, anatomic location of disease involvement, and disease duration, affected the relationship between skin changes and symptoms and downstream functioning and general health perceptions.

CONCLUSIONS AND RELEVANCE

This qualitative analysis demonstrated the direct relationship between cutaneous chronic GVHD and HRQOL domains and identified codes not represented in existing GVHD- and dermatology-specific patient-reported outcome measures. These results can guide patient-reported outcome development and instrument selection for clinical trials and improve clinical decision-making.

摘要

重要性

皮肤慢性移植物抗宿主病(GVHD)与异基因造血细胞移植后的发病率和死亡率独立相关。然而,对于患者而言最重要的健康相关生活质量(HRQOL)领域却鲜为人知。

目的

开展一项概念引发研究,从患者角度定义皮肤慢性GVHD中的HRQOL,并比较表皮疾病与硬化性疾病患者的经历。

设计、背景和参与者:2023年4月至9月间进行的一项单中心定性分析,采用开放式、半结构化访谈以及自由列举术语的方式。参与者年龄在18岁及以上,诊断为活动性皮肤慢性GVHD,根据表皮和硬化性疾病特征进行有目的抽样,持续抽样直至主题饱和。

主要结果

通过对半结构化访谈的归纳分析,从患者角度确定了皮肤慢性GVHD患者生活中的HRQOL领域和编码。根据去识别化患者访谈中的自由列举术语计算了史密斯显著性指数(Smith S)得分,该得分用于衡量每个列表术语的显著性。

结果

共有31名患有皮肤慢性GVHD的成年人(年龄中位数[四分位间距]为61.1[52.9 - 68.7]岁)参与了访谈;17名参与者(54.8%)为男性,14名(45.2%)为女性。9名参与者(29.0%)患有表皮疾病,13名(41.9%)患有硬化性疾病,9名(29.0%)患有两种疾病类型的组合。该研究确定了40个重要编码,分为5个HRQOL领域:皮肤变化和症状、社会功能、心理和情感功能、身体功能以及总体健康认知。最常见症状为皮肤干燥(n = 20[65%])、皮肤紧绷(n = 19[61%])、瘙痒(n = 15[48%])和色素沉着(n = 14[45%]),所有疾病亚型均有出现。所有参与者均指出社会功能受损。心理和情感功能,包括沮丧(Smith S得分0.32)和担忧(Smith S得分0.12),以及包括不适(Smith S得分0.

相似文献

1
Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease.对患有皮肤慢性移植物抗宿主病患者具有重要意义的结局。
JAMA Dermatol. 2025 Mar 1;161(3):281-290. doi: 10.1001/jamadermatol.2024.5380.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.多克隆抗胸腺细胞球蛋白用于预防成人异基因干细胞或骨髓移植后的移植物抗宿主病。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD009159. doi: 10.1002/14651858.CD009159.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
7
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.成人血液系统恶性肿瘤的骨髓与外周血异基因造血干细胞移植。
Cochrane Database Syst Rev. 2024 Nov 7;11(11):CD010189. doi: 10.1002/14651858.CD010189.pub3.
8
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比,HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
9
Can We Enhance Shared Decision-making for Periacetabular Osteotomy Surgery? A Qualitative Study of Patient Experiences.我们能否加强髋臼周围截骨术的共同决策?一项关于患者体验的定性研究。
Clin Orthop Relat Res. 2025 Jan 1;483(1):120-136. doi: 10.1097/CORR.0000000000003198. Epub 2024 Jul 23.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.患者报告结局与皮肤慢性移植物抗宿主病的死亡率。
JAMA Dermatol. 2024 Apr 1;160(4):393-401. doi: 10.1001/jamadermatol.2023.6277.
2
Identifying Core Outcome Domains in Chronic Skin Disease Using the Best-Worst Scaling Method.采用最佳最差标度法确定慢性皮肤病的核心结局领域。
JAMA Dermatol. 2024 Apr 1;160(4):441-446. doi: 10.1001/jamadermatol.2023.6245.
3
Understanding Discordant Perceptions of Disease Severity Between Physicians and Patients With Eczema and Psoriasis Using Structural Equation Modeling.利用结构方程模型理解湿疹和银屑病患者与医生对疾病严重程度的认知差异。
JAMA Dermatol. 2023 Aug 1;159(8):811-819. doi: 10.1001/jamadermatol.2023.2008.
4
Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.慢性移植物抗宿主病患者皮肤疾病严重程度估计对生存结局的预后价值。
JAMA Dermatol. 2023 Apr 1;159(4):393-402. doi: 10.1001/jamadermatol.2022.6624.
5
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium.慢性移植物抗宿主病患者的非复发死亡率:慢性移植物抗宿主病联盟的更新分析。
Blood Adv. 2021 Oct 26;5(20):4278-4284. doi: 10.1182/bloodadvances.2021004941.
6
Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis.患者报告结局测量作为补充信息与临床医生报告结局测量在银屑病患者中的应用。
JAMA Dermatol. 2021 Oct 1;157(10):1236-1237. doi: 10.1001/jamadermatol.2021.3341.
7
"This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.“移植物抗宿主病决定了我的生活。就是这样。”-德国异基因造血干细胞移植幸存者的经历和需求的定性分析。
Front Public Health. 2021 Jul 1;9:687675. doi: 10.3389/fpubh.2021.687675. eCollection 2021.
8
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.贝罗莫苏德利治疗 2 线及以上治疗后的慢性移植物抗宿主病:ROCKstar 研究。
Blood. 2021 Dec 2;138(22):2278-2289. doi: 10.1182/blood.2021012021.
9
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.芦可替尼治疗糖皮质激素难治性慢性移植物抗宿主病。
N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122.
10
"Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.“这是移植物抗宿主病吗?”一项对异基因造血干细胞移植后发生移植物抗宿主病的个体的生活质量问题及其对专科多学科骨髓移植服务的体验的定性研究。
Health Qual Life Outcomes. 2021 Jan 7;19(1):11. doi: 10.1186/s12955-020-01651-2.